SPRY Stock Ownership Activity

ARS PHARMACEUTICALS INC 13F holders

1 value investing guru has made changes to the ARS PHARMACEUTICALS INC (SPRY) position according to the gurus' latest SEC quarterly report(s). The number of SPRY shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying SPRY now?

According to the latest SEC filing(s) ARS PHARMACEUTICALS INC (SPRY) has been bought by Daniel Loeb - Third Point (added shares +79.78%).

To see more about who is investing in ARS PHARMACEUTICALS INC (SPRY), please go to the SPRY ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2026 Q1 (1 result)
Daniel Loeb
Third Point
+79.78%
+443,763
+0.17%
0.39%
Current price: $8.75 8.97% Reported price*: $8.03
2025 Q4 (1 result)
Daniel Loeb
Third Point
buy
+556,237
+0.09%
0.09%
Current price: $8.75 24.89% Reported price*: $11.65
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.